Fuxiang Pharmaceutical: It is expected that the net profit will be between RMB 39 million and RMB 57 million in 2025.

Fu Xiang Pharmaceutical announced that it is expected to incur a net loss of 39-57 million yuan in 2025. It is estimated that the impact of non-recurring gains and losses on the company's net profit during the reporting period will be around 30 million yuan.